WAY-324924 is primarily used in scientific research as a selective agonist for the 5-HT2C receptor, making it a valuable tool for studying serotonin signaling pathways in the central nervous system. It has been investigated for its potential role in modulating behaviors related to appetite, mood, and impulse control. Due to its action on 5-HT2C receptors, which are involved in regulating dopamine release, it has been explored in preclinical studies for applications in treating obesity, depression, and substance use disorders. Its selectivity helps minimize off-target effects, allowing researchers to isolate the physiological effects of 5-HT2C activation. However, it remains strictly for experimental use and has not been approved for clinical or therapeutic applications.